Ob-Gyn Coding Alert

News You Can Use:
Say Goodbye to Surgical Mesh Products for Pelvic Organ Prolapses

FDA has removed mesh products from the market. On April 16, the FDA decided to eliminate mesh as a potential option for patients suffering from pelvic organ prolapse (POP) or stress urinary incontinence (SUI). That means you shouldn’t see any more transvaginal repair of anterior compartment (cystocele) claims featuring mesh. If you do, you could likely expect to see a [...]